India's Mankind Licenses Entresto From Novartis, Acquires Panacea’s Brands
$1Bn Revenue Forecast For FY22
Mankind Pharma has licensed Novartis’ heart failure therapy Entresto in India, executive chairman Ramesh Juneja tells Scrip. The privately-owned company has also acquired the generics business of Panacea in India and Nepal for over $255m.
